Arcutis Biotherapeutics, Inc. - 8-K Filing

Arcutis Biotherapeutics appoints Christopher Peetz to its Board of Directors, effective July 15, 2026. (Items: 7.01 Regulation FD Disclosure)

SEC EDGAR ·

Tickers: $ARQT

Read the full article at SEC EDGAR

More Regulatory news